U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Citrullinemia, type II, adult-onset(CTLN2)

MedGen UID:
976464
Concept ID:
CN295299
Disease or Syndrome
Synonyms: Adult-onset citrullinemia type 2; CTLN2
 
Gene (location): SLC25A13 (7q21.3)
 
Monarch Initiative: MONDO:0011326
OMIM®: 603471

Disease characteristics

Excerpted from the GeneReview: Citrin Deficiency
Citrin deficiency can manifest in newborns or infants as neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), in older children as failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD), and in adults as recurrent hyperammonemia with neuropsychiatric symptoms in citrullinemia type II (CTLN2). Often citrin deficiency is characterized by strong preference for protein-rich and/or lipid-rich foods and aversion to carbohydrate-rich foods. NICCD. Children younger than age one year have a history of low birth weight with growth restriction and transient intrahepatic cholestasis, hepatomegaly, diffuse fatty liver, and parenchymal cellular infiltration associated with hepatic fibrosis, variable liver dysfunction, hypoproteinemia, decreased coagulation factors, hemolytic anemia, and/or hypoglycemia. NICCD is generally not severe and symptoms often resolve by age one year with appropriate treatment, although liver transplantation has been required in rare instances. FTTDCD. Beyond age one year, many children with citrin deficiency develop a protein-rich and/or lipid-rich food preference and aversion to carbohydrate-rich foods. Clinical abnormalities may include growth restriction, hypoglycemia, pancreatitis, severe fatigue, anorexia, and impaired quality of life. Laboratory changes are dyslipidemia, increased lactate-to-pyruvate ratio, higher levels of urinary oxidative stress markers, and considerable deviation in tricarboxylic acid (TCA) cycle metabolites. One or more decades later, some individuals with NICCD or FTTDCD develop CTLN2. CTLN2. Presentation is sudden and usually between ages 20 and 50 years. Manifestations are recurrent hyperammonemia with neuropsychiatric symptoms including nocturnal delirium, aggression, irritability, hyperactivity, delusions, disorientation, restlessness, drowsiness, loss of memory, flapping tremor, convulsive seizures, and coma. Symptoms are often provoked by alcohol and sugar intake, medication, and/or surgery. Affected individuals may or may not have a prior history of NICCD or FTTDCD. [from GeneReviews]
Authors:
Takeyori Saheki  |  Yuan-Zong Song   view full author information

Additional description

From OMIM
Adult-onset type II citrullinemia is an autosomal recessive metabolic disorder characterized clinically by the sudden onset of various neuropsychologic symptoms such as disorientation, abnormal behavior, convulsions, and coma due to hyperammonemia. In some cases, rapid progression can lead to brain edema and death if liver transplantation is not possible. Some patients may present with nonalcoholic hepatic steatosis or may develop hepatic fibrosis or hepatocellular carcinoma. Patients with this disorder have a natural aversion to carbohydrates and favor protein, which is in contrast to protein aversion usually observed in patients with urea cycle defects (summary by Komatsu et al., 2008).  http://www.omim.org/entry/603471

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Professional guidelines

PubMed

Hayasaka K
J Inherit Metab Dis 2021 Jan;44(1):110-117. Epub 2020 Aug 26 doi: 10.1002/jimd.12294. PMID: 32740958
Okano Y, Ohura T, Sakamoto O, Inui A
Mol Genet Metab 2019 Jul;127(3):175-183. Epub 2019 Jun 15 doi: 10.1016/j.ymgme.2019.06.004. PMID: 31255436
Yamaguchi N, Kobayashi K, Yasuda T, Nishi I, Iijima M, Nakagawa M, Osame M, Kondo I, Saheki T
Hum Mutat 2002 Feb;19(2):122-30. doi: 10.1002/humu.10022. PMID: 11793471

Curated

American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Citrin Deficiency, Citrullinemia II, Urea Cycle Disorder, 2012

Recent clinical studies

Etiology

Komatsu M, Tanaka N, Kimura T, Yazaki M
Nutrients 2023 May 12;15(10) doi: 10.3390/nu15102284. PMID: 37242166Free PMC Article
Okamoto M, Okano Y, Okano M, Yazaki M, Inui A, Ohura T, Murayama K, Watanabe Y, Tokuhara D, Takeshima Y
Nutrients 2021 Sep 6;13(9) doi: 10.3390/nu13093123. PMID: 34579000Free PMC Article
Pinto A, Ashmore C, Batzios S, Daly A, Dawson C, Dixon M, Evans S, Green D, Gribben J, Hunjan I, Jameson E, Newby C, Pierre G, Rajwal S, Robertson L, Santra S, Sharrard M, Vara R, White L, Wilcox G, Yilmaz O, MacDonald A
Nutrients 2020 Oct 29;12(11) doi: 10.3390/nu12113313. PMID: 33137944Free PMC Article
Hirayama S, Nagasaka H, Honda A, Komatsu H, Kodama T, Inui A, Morioka I, Kaji S, Ueno T, Ihara K, Yagi M, Kizaki Z, Bessho K, Kondou H, Yorifuji T, Tsukahara H, Iijima K, Miida T
J Clin Endocrinol Metab 2018 Jul 1;103(7):2488-2497. doi: 10.1210/jc.2017-02664. PMID: 29659898
Song YZ, Zhang ZH, Lin WX, Zhao XJ, Deng M, Ma YL, Guo L, Chen FP, Long XL, He XL, Sunada Y, Soneda S, Nakatomi A, Dateki S, Ngu LH, Kobayashi K, Saheki T
PLoS One 2013;8(9):e74544. Epub 2013 Sep 19 doi: 10.1371/journal.pone.0074544. PMID: 24069319Free PMC Article

Diagnosis

Komatsu M, Tanaka N, Kimura T, Yazaki M
Nutrients 2023 May 12;15(10) doi: 10.3390/nu15102284. PMID: 37242166Free PMC Article
Pinto A, Ashmore C, Batzios S, Daly A, Dawson C, Dixon M, Evans S, Green D, Gribben J, Hunjan I, Jameson E, Newby C, Pierre G, Rajwal S, Robertson L, Santra S, Sharrard M, Vara R, White L, Wilcox G, Yilmaz O, MacDonald A
Nutrients 2020 Oct 29;12(11) doi: 10.3390/nu12113313. PMID: 33137944Free PMC Article
Kakiuchi T, Nakayama A, Akiyama T, Martsuo M
Clin J Gastroenterol 2020 Feb;13(1):97-101. Epub 2019 Jun 29 doi: 10.1007/s12328-019-01011-8. PMID: 31256334
Kikuchi A, Arai-Ichinoi N, Sakamoto O, Matsubara Y, Saheki T, Kobayashi K, Ohura T, Kure S
Mol Genet Metab 2012 Apr;105(4):553-8. Epub 2012 Jan 8 doi: 10.1016/j.ymgme.2011.12.024. PMID: 22277121
Ko JS, Song JH, Park SS, Seo JK
J Korean Med Sci 2007 Dec;22(6):952-6. doi: 10.3346/jkms.2007.22.6.952. PMID: 18162705Free PMC Article

Therapy

Hayasaka K
J Inherit Metab Dis 2021 Jan;44(1):110-117. Epub 2020 Aug 26 doi: 10.1002/jimd.12294. PMID: 32740958
Pinto A, Ashmore C, Batzios S, Daly A, Dawson C, Dixon M, Evans S, Green D, Gribben J, Hunjan I, Jameson E, Newby C, Pierre G, Rajwal S, Robertson L, Santra S, Sharrard M, Vara R, White L, Wilcox G, Yilmaz O, MacDonald A
Nutrients 2020 Oct 29;12(11) doi: 10.3390/nu12113313. PMID: 33137944Free PMC Article
Okano Y, Ohura T, Sakamoto O, Inui A
Mol Genet Metab 2019 Jul;127(3):175-183. Epub 2019 Jun 15 doi: 10.1016/j.ymgme.2019.06.004. PMID: 31255436
Hayasaka K, Numakura C, Yamakawa M, Mitsui T, Watanabe H, Haga H, Yazaki M, Ohira H, Ochiai Y, Tahara T, Nakahara T, Yamashiki N, Nakayama T, Kon T, Mitsubuchi H, Yoshida H
J Inherit Metab Dis 2018 Sep;41(5):777-784. Epub 2018 Apr 12 doi: 10.1007/s10545-018-0176-1. PMID: 29651749
Saheki T, Kobayashi K, Terashi M, Ohura T, Yanagawa Y, Okano Y, Hattori T, Fujimoto H, Mutoh K, Kizaki Z, Inui A
J Inherit Metab Dis 2008 Jun;31(3):386-94. Epub 2008 Apr 14 doi: 10.1007/s10545-008-0752-x. PMID: 18415701

Prognosis

Tavoulari S, Lacabanne D, Thangaratnarajah C, Kunji ERS
Trends Endocrinol Metab 2022 Aug;33(8):539-553. Epub 2022 Jun 17 doi: 10.1016/j.tem.2022.05.002. PMID: 35725541Free PMC Article
Kido J, Häberle J, Sugawara K, Tanaka T, Nagao M, Sawada T, Wada Y, Numakura C, Murayama K, Watanabe Y, Kojima-Ishii K, Sasai H, Kosugiyama K, Nakamura K
J Inherit Metab Dis 2022 May;45(3):431-444. Epub 2022 Feb 25 doi: 10.1002/jimd.12483. PMID: 35142380
Hayasaka K, Numakura C, Yamakawa M, Mitsui T, Watanabe H, Haga H, Yazaki M, Ohira H, Ochiai Y, Tahara T, Nakahara T, Yamashiki N, Nakayama T, Kon T, Mitsubuchi H, Yoshida H
J Inherit Metab Dis 2018 Sep;41(5):777-784. Epub 2018 Apr 12 doi: 10.1007/s10545-018-0176-1. PMID: 29651749
Kikuchi A, Arai-Ichinoi N, Sakamoto O, Matsubara Y, Saheki T, Kobayashi K, Ohura T, Kure S
Mol Genet Metab 2012 Apr;105(4):553-8. Epub 2012 Jan 8 doi: 10.1016/j.ymgme.2011.12.024. PMID: 22277121
Takaya J, Kobayashi K, Ohashi A, Ushikai M, Tabata A, Fujimoto S, Yamato F, Saheki T, Kobayashi Y
Metabolism 2005 Dec;54(12):1615-9. doi: 10.1016/j.metabol.2005.06.009. PMID: 16311094

Clinical prediction guides

Tavoulari S, Lacabanne D, Thangaratnarajah C, Kunji ERS
Trends Endocrinol Metab 2022 Aug;33(8):539-553. Epub 2022 Jun 17 doi: 10.1016/j.tem.2022.05.002. PMID: 35725541Free PMC Article
Kakiuchi T, Nakayama A, Akiyama T, Martsuo M
Clin J Gastroenterol 2020 Feb;13(1):97-101. Epub 2019 Jun 29 doi: 10.1007/s12328-019-01011-8. PMID: 31256334
Wang L, Wang L, Zhu S, Zhang M, Dong Y, Wang FS
Pediatrics 2019 Jan;143(1) doi: 10.1542/peds.2018-1931. PMID: 30591617
Hayasaka K, Numakura C, Yamakawa M, Mitsui T, Watanabe H, Haga H, Yazaki M, Ohira H, Ochiai Y, Tahara T, Nakahara T, Yamashiki N, Nakayama T, Kon T, Mitsubuchi H, Yoshida H
J Inherit Metab Dis 2018 Sep;41(5):777-784. Epub 2018 Apr 12 doi: 10.1007/s10545-018-0176-1. PMID: 29651749
Okano Y, Kobayashi K, Ihara K, Ito T, Yoshino M, Watanabe Y, Kaji S, Ohura T, Nagao M, Noguchi A, Mushiake S, Hohashi N, Hashimoto-Tamaoki T
Mol Genet Metab 2013 May;109(1):9-13. Epub 2013 Feb 9 doi: 10.1016/j.ymgme.2013.01.020. PMID: 23453692

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • ACMG ACT, 2012
      American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Citrin Deficiency, Citrullinemia II, Urea Cycle Disorder, 2012

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...